Skip to main content
SpringerLink
Log in

Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors

  • Original Paper
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

An intimate interplay exists between the bone and the immune system, which has been recently termed osteoimmunology. The activity of immune cells affects the intrinsic balance of bone mineralization and resorption carried out by the opposing actions of osteoblasts and osteoclasts. The aim of this study was to determine the possible interaction between inflammatory-induced conditions and matrix metalloproteinases-2,-9 (MMP-2,-9) synthesis and secretion by bone marrow-derived osteoprogenitor cells during advanced stages of osteogenesis. Rat bone marrow-derived mesenchymal stem cells (MSCs) were cultured in the presence of osteogenic supplements in order to direct the cells towards the osteogenic differentiation lineage. At the late stages of osteogenesis, assessed by histochemistry, immunohistochemistry and RT-PCR, cultures were exposed to pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1alpha (IL-1α). Biochemical, histochemical and molecular biology techniques were used to discern the influence of pro-inflammatory cytokines on MMP-2,-9 synthesis and secretion. Results indicated that MMP-9 synthesis and secretion were significantly induced after exposure to the cytokines (TNF-α, IL-1α) treatment, while MMP-2 levels remained unchanged. These results indicate that in response to inflammatory processes, osteoblasts, in addition to osteoclasts, can also be involved and contribute to the process of active bone resorption by secretion and activation of MMPs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Aimes RT, Quigley JP (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270:5872–5876

    Article  PubMed  CAS  Google Scholar 

  • Beck GR Jr. (2003) Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90:234–243

    Article  PubMed  CAS  Google Scholar 

  • Bergmann U, Tuuttila A, Stetler-Stevenson WG, Tryggvason K (1995) Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry 34:2819–2825

    Article  PubMed  CAS  Google Scholar 

  • Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG (1990) Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:6184–6191

    PubMed  CAS  Google Scholar 

  • Clowes JA, Riggs BL, Khosla S (2005) The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208:207–227

    Article  PubMed  CAS  Google Scholar 

  • Everts V, Delaisse JM, Korper W, Beertsen W (1998) Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13:1420–1430

    Article  PubMed  CAS  Google Scholar 

  • Fujisaki K, Tanabe N, Suzuki N, Mitsui N, Oka H, Ito K, Maeno M (2006) The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Life Sci 78:1975–1982

    Article  PubMed  CAS  Google Scholar 

  • Gepstein A, Shapiro S, Arbel G, Lahat N, Livne E (2002) Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging. Arthritis Rheum 46:3240–3250

    Article  PubMed  CAS  Google Scholar 

  • Gepstein A, Arbel G, Blumenfeld I, Peled M, Livne E (2003) Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint. Histochem Cell Biol 120:23–32

    Article  PubMed  CAS  Google Scholar 

  • Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteoporosis, inflammation and ageing. Immun Ageing 2:14

    Article  PubMed  Google Scholar 

  • Groft LL, Muzik H, Rewcastle NB, Johnston RN, Knauper V, Lafleur MA, Forsyth PA, Edwards DR (2001) Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer 85:55–63

    Article  PubMed  CAS  Google Scholar 

  • Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6:199–213

    Article  PubMed  CAS  Google Scholar 

  • Kolkenbrock H, Orgel D, Hecker-Kia A, Zimmermann J, Ulbrich N (1995) Generation and activity of the ternary gelatinase B/TIMP-1/LMW-stromelysin-1 complex. Biol Chem Hoppe Seyler 376:495–500

    PubMed  CAS  Google Scholar 

  • Kolkenbrock H, Hecker-Kia A, Orgel D, Kinawi A, Ulbrich N (1996) Progelatinase B forms from human neutrophils. Complex formation of monomer/lipocalin with TIMP-1. Biol Chem 377:529–533

    PubMed  CAS  Google Scholar 

  • Lin SK, Kok SH, Kuo MY, Lee MS, Wang CC, Lan WH, Hsiao M, Goldring SR, Hong CY (2003) Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts. J Bone Miner Res 18:39–46

    Article  PubMed  Google Scholar 

  • Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40(1):46–62

    Article  PubMed  CAS  Google Scholar 

  • Mizutani A, Sugiyama I, Kuno E, Matsunaga S, Tsukagoshi N (2001) Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 16:2043–2049

    Article  PubMed  CAS  Google Scholar 

  • Moll UM, Youngleib GL, Rosinski KB, Quigley JP (1990) Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50:6162–6170

    PubMed  CAS  Google Scholar 

  • Morgan H, Hill PA (2005) Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int [electronic resource] 5:1

    Article  CAS  Google Scholar 

  • Murphy G, Willenbrock F, Crabbe T, O’Shea M, Ward R, Atkinson S, O’Connell J, Docherty A (1994) Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 732:31–41

    Article  PubMed  CAS  Google Scholar 

  • Parikka V, Vaananen A, Risteli J, Salo T, Sorsa T, Vaananen HK, Lehenkari P (2005) Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol 24(6):438–447

    Article  PubMed  CAS  Google Scholar 

  • Patterson ML, Atkinson SJ, Knauper V, Murphy G (2001) Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 503:158–162

    Article  PubMed  CAS  Google Scholar 

  • Pepper MS (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104–1117

    Article  PubMed  CAS  Google Scholar 

  • Philip S, Bulbule A, Kundu GC (2004) Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J 21:429–441

    Article  PubMed  CAS  Google Scholar 

  • Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K (1994) High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091–1102

    Article  PubMed  CAS  Google Scholar 

  • Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus HG (1994) Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134:213–221

    Article  PubMed  CAS  Google Scholar 

  • Roodman GD (1999) Cell biology of the osteoclast. Exp Hematol 27:1229–1241

    Article  PubMed  CAS  Google Scholar 

  • Saftig P, Hunziker E, Everts V, Jones S, Boyde A, Wehmeyer O, Suter A, von Figura K (2000) Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477:293–303

    Article  PubMed  CAS  Google Scholar 

  • Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knauper V, Murphy G, Timpl R (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237–9243

    Article  PubMed  CAS  Google Scholar 

  • Srouji S, Maurice S, Livne E (2005) Microscopy analysis of bone marrow-derived osteoprogenitor cells cultured on hydrogel 3-D scaffold. Microsc Res Tech 66:132–138

    Article  PubMed  CAS  Google Scholar 

  • Uchida M, Shima M, Shimoaka T, Fujieda A, Obara K, Suzuki H, Nagai Y, Ikeda T, Yamato H, Kawaguchi H (2000) Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol 185:207–214

    Article  PubMed  CAS  Google Scholar 

  • Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE, Stashenko P (1994) Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res 9:549–556

    Article  PubMed  CAS  Google Scholar 

  • Ylisirnio S, Hoyhtya M, Makitaro R, Paaakko P, Risteli J, Kinnula VL, Turpeenniemi-Hujanen T, Jukkola A (2001) Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res 7:1633–1637

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work has been supported by the Israel Ministry of Commerce, Magnet Grant No. 2007992 and by Joint-Brookdale Gerontology Institute, and a grant from the Krol Founadtion of Barnegat NJ. USA to AZR. The excellent technical work of Mrs Pessia Schenzer and Mrs Janette Zavin is also acknowledged.

Author information

Authors and Affiliations

  1. Department of Anatomy and Cell Biology, Faculty of Medicine, Technion, P.O. Box 9649, 31096, Haifa, Israel

    D. Ben David, A. Z. Reznick, S. Srouji & E. Livne

  2. Department of Maxillofacial Surgery, Carmel Medical Center, Haifa, Israel

    S. Srouji

Authors
  1. D. Ben David
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Z. Reznick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Srouji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Livne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Livne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ben David, D., Reznick, A.Z., Srouji, S. et al. Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Histochem Cell Biol 129, 589–597 (2008). https://doi.org/10.1007/s00418-008-0391-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-008-0391-1

Keywords

Search

Navigation